By www.reliableresearchtimes.com
Global Peripheral Arterial Disease (PAD) Drugs Market Size, Status And Forecast 2024-2031 Story
96
$ 3900
Peripheral Arterial Disease (PAD) Drugs Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
AstraZeneca (UK) Bayer HealthCare Pharmaceuticals (Germany) Bristol-Myers Squibb Company (US) Merck & Co (US) Proteon Therapeutics (US) Sanofi (France) Symic Bio (US) TheraVasc (US)